Fetal brain response to maternal inflammation requires microglia.
Bridget Elaine LaMonica OstremNuria Domínguez-IturzaJeffrey A StogsdillTyler FaitsKwanho KimJoshua Z LevinPaola ArlottaPublished in: Development (Cambridge, England) (2024)
In utero infection and maternal inflammation can adversely impact fetal brain development. Maternal systemic illness, even in the absence of direct fetal brain infection, is associated with an increased risk of neuropsychiatric disorders in affected offspring. The cell types mediating the fetal brain response to maternal inflammation are largely unknown, hindering the development of novel treatment strategies. Here, we show that microglia, the resident phagocytes of the brain, highly express receptors for relevant pathogens and cytokines throughout embryonic development. Using a rodent maternal immune activation (MIA) model in which polyinosinic:polycytidylic acid is injected into pregnant mice, we demonstrate long-lasting transcriptional changes in fetal microglia that persist into postnatal life. We find that MIA induces widespread gene expression changes in neuronal and non-neuronal cells; importantly, these responses are abolished by selective genetic deletion of microglia, indicating that microglia are required for the transcriptional response of other cortical cell types to MIA. These findings demonstrate that microglia play a crucial durable role in the fetal response to maternal inflammation, and should be explored as potential therapeutic cell targets.
Keyphrases
- gene expression
- birth weight
- inflammatory response
- resting state
- oxidative stress
- white matter
- pregnancy outcomes
- neuropathic pain
- cerebral ischemia
- single cell
- functional connectivity
- induced apoptosis
- dna methylation
- pregnant women
- transcription factor
- stem cells
- multiple sclerosis
- weight gain
- spinal cord
- cell death
- bone marrow
- insulin resistance
- adipose tissue
- heat shock
- gram negative
- multidrug resistant
- endoplasmic reticulum stress